Abstract:Alzheimer's disease(AD) is a progressive neurodegenerative disorder that affects the elderly. Clinical studies have found that the amyloid deposits in the brain are aggravated along with the deterioration of the AD pathology. Indeed,Aβ peptides change particularly significantly early in the preclinical stage,and then detection of Aβ is of great importance in early diagnosis. Therefore,it is critical to diagnose and treat AD at the preclinical stage,and Aβ becomes the key target of international research. We also focus on risk factors for preclinical Alzheimer's disease,especially imbalance in lipid metabolism. Our current study presented a novel model with early onset of cognitive dysfunction by phospholipid transfer protein(PLTP) deficiency in APP/PS1ΔE9 mice without appearance of amyloid deposition. Dysfunction of PLTP might be a risk factor for the elevated Aβ in the preclinical stage of AD. We first found several potential functions of PLTP deficiency in the AD model mice:impairing cognitive performance;involvement in APP trafficking/processing and intracellular Aβ generation;inducing Aβ42 related alteration of BDNF. These established PLTP deficient AD mouse models could provide insights to early stages in AD like mild cognitive impairment(MCI) or preclinical AD(PCAD). Lipoprotein lipase(LPL) is expressed at high levels in hippocampal neurons,although its function is unclear. Lipoprotein lipase(LPL) is expressed at high levels in hippocampal neurons, although its function is unclear. We previously reported that LPL-deficient mice have learning and memory impairment and fewer synaptic vesicles in hippocampal neurons,but properties of synaptic activity in LPL-deficient neurons remain unexplored. In this study,we found reduced frequency of miniature excitatory postsynaptic currents(mEPSCs) and readily releasable pool(RRP) size in LPL-deficient neurons,which led to presynaptic dysfunction and plasticity impairment without altering postsynaptic activity. We demonstrated that synaptic vesicle recycling,which is known to play an important role in maintaining the RRP size in active synapses,is impaired in LPL-deficient neurons. Moreover,lipid assay revealed deficient docosahexaenoic acid(DHA) and arachidonic acid(AA) in the hippocampus of LPL-deficient mice;exogenous DHA or AA supplement partially restored synaptic vesicle recycling capability. These results suggest that impaired synaptic vesicle recycling results from defi cient DHA and AA and contributes to the presynaptic dysfunction and plasticity impairment in LPL-defi cient neurons. Accumulating evidence supported thatα-synuclein(α-syn) and ubiquitin C-terminal hydrolase L1(UCHL1) are required for normal synaptic and cognitive function. In this study,we found thatα-syn aggregated and the expression of UCHL1 decreased in the brain of LPL defi cient mice. Reduction of UCHL1 was resulted from nuclear retention of DNA cytosine-5-methyltransferase 1 in LPL knockout mice. Reverse changes were found in cultured cells overexpressing LPL. Furthermore,defi ciency of LPL increased ubiquitination ofα-syn. These results indicated that aggregation ofα-syn and reduction of UCHL1 expression in LPL-defi cient mice may affect synaptic function.

Implication of Lipid Related Risk Factor for Preclinical Stage Alzheimer's Disease:Lipoprotein Lipase deficiency Leads to α-synuclein Aggregation and Impaired Learning and Memory Function

Implication of lipid metabolism disturbance and Alzheimer’s disease: focus on the lipoprotein lipase plays an important role in learning and memory function

Lipoprotein Lipase Deficiency Leads to Α-Synuclein Aggregation and Ubiquitin C-terminal Hydrolase L1 Reduction.

Presynaptic Defects Underlying Impaired Learning and Memory Function in Lipoprotein Lipase-Deficient Mice

Impaired Synaptic Vesicle Recycling Contributes to Presynaptic Dysfunction in Lipoprotein Lipase-Deficient Mice.

Phospholipid Transfer Protein (pltp) Deficiency Accelerates Memory Dysfunction Through Altering Amyloid Precursor Protein (app) Processing in A Mouse Model of Alzheimer'S Disease

Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer’s Disease: from Physiological Performance to Pathological Impairment

Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation

Pltp Deficiency Impairs Learning And Memory Capabilities Partially Due To Alteration Of Amyloid-Beta Metabolism In Old Mice

Genetic Variants Of Lipoprotein Lipase And Regulatory Factors Associated With Alzheimer'S Disease Risk

Microglia-Dependent and Independent Modulation of Brain Lipid Metabolism in Alzheimer's Disease Revealed by Pharmacological and Genetic Microglial Depletion

Exploration of the Molecular Mechanism for Lipoprotein Lipase Expression Variations in SH-SY5Y Cells Exposed to Different Doses of Amyloid-Beta Protein

Early Memory Deficits Precede Plaque Deposition in APPswe/PS1dE9 Mice: Involvement of Oxidative Stress and Cholinergic Dysfunction.

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease

Untargeted Lipidomics Reveals Progression of Early Alzheimer’s Disease in APP/PS1 Transgenic Mice

Hippocampus proteomics and brain lipidomics reveal network dysfunction and lipid molecular abnormalities in APP/PS1 mouse model of Alzheimer's disease.

Brain Lipid Dynamics in Amyloid Precursor Protein/Presenilin 1 Mouse Model of Early Alzheimer's Disease by Desorption Electrospray Ionization and Matrix Assisted Laser Desorption Ionization-Mass Spectrometry Imaging Techniques

Early Disruption of Synaptic Function, Impairment of Plasticity, and Decreased of Cortical Circuit Connectivity in an Alzheimer’S Mouse Model of Amyloid Deposition

Loss of neuronal lysosomal acid lipase drives amyloid pathology in Alzheimer's disease

Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer’s Disease

Alterations of fatty acid composition and metabolism in APP/PS1 transgenic mice